Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results.
Jacek MackiewiczTomasz BurzykowskiDariusz IżyckiAndrzej MackiewiczPublished in: Journal for immunotherapy of cancer (2018)
Central Evidence of Clinical Trials (EudraCT Number 2008-003373-40 ).